'Epidemics that used to be excused as acts of God are now not excused as the results of the inactivity of man. In short, the incidence of many diseases has been moved from the area of chance to the area of choice. That is a vast change intellectually. Not only intellectually but also morally, for such a series of accomplishments leaves us with a new system of ethics to devise, somewhat as the perfection of the automobile has called for new traffic laws. As physicians we cannot evade a moral responsibility that goes with our newly acquired power. Having learned how disease comes about, we find ourselves answerable for why it should occur at all' (Gregg, 1949 ).
THE EFFECTIVE control or eradication of many infectious diseases through prophylactic immunization stands as one of the more dramatic success stories of moder medicine. The number of diseases amenable to prevention is increasing in recent years, and new developments on the horizon may be expected to further compound the already complicated immunization schedule. We have arrived at the point where, from infancy through young adulthood, the individual will receive a formidable array of biological products for the prevention of disease on a routine basis. Decisions concerning the optimal use of immunizing agents have attained a high degree of sophistication, stemming from a number of very real factors. Expert opinion has been divided on many issues. Matters of fine judgment and public policy are involved. Thus, the individual practitioner or public health officer finds that he must become learned in such areas as: the relative merits of inactivated versus live attenuated virus vaccines; the effect of adjuvants; the optimal sequence and interval of administration; the efficiency and safety of available products; the identification of high risk groups to be singled out for special immunization schedules; the contraindications to administration of individual products; the attributes of newlyintroduced biologicals and weighing of risk of disease against the risk of the immunizing procedure; the legitimacy of universal immunization against a disease which is absent or uncommon in the population; and the problems of simultaneous administration of immunizing agents, especially one or more live products.
Final judgment on the safest and most effective procedures to use for the immunization of the individual, community or nation rests on a complex balance of factors. More and more, the individual practitioner and the public health authorities have looked for guidance from expert national bodies. This guidance in recent years has been based increasingly on pre-designed studies such as vaccine field trials, surveillance of disease morbidity and mortality, sero-epidemiology, and surveillance of the untoward effects of vaccines. These data are then weighed against the practicalities of scheduling such immunizations within the existing patterns of delivery of health care.
The present article is an attempt to explore some of the problems and solutions undertaken in the field of immunization practice in the United States and Great Britain. A very limited review in the two countries has shown that, despite the disparate systems of delivery of health care, similar trends in immunization practice have developed. Furthermore, the rate of use of various products and their effectiveness in reduction of disease again shows more resemblances than differences. One (Freckleton, 1967 Diphtheria, tetanus and pertussis The three diseases may be discussed profitably under one heading, because of the current general practice of immunization with combined antigens. (Strom, 1960 (Edsall, 1961 (Preston, 1965 Fig. 4 (Miller & Galbraith, 1965) 1I 1941 1945 1949 1953 1957 1961 1965 1969 1943 1947 1951 1955 1959 1963 1967 1950. 1952 1954 1956 1958 1960 1962 1964 (Miller & Galbraith, 1965) . Weighing the benefits of poliovaccine against the minute risks involved, its routine use appears to be well justified. (Neff et al., 1967b) . t 3,820,000 primary vaccinations (1951-60) (Conybeare, 1964) . (Neff et al., 1967b) .
: 3,820,000 primary and 1,240,000 revaccinations (1951-60) (Conybeare, 1964) .
England and Wales was reported routinely to the health authorities (Conybeare, 1964) (Table 7) (Neff et al., 1967b) .
In the United States, official policy has always been rather firm in advocating universal smallpox immunization, although this policy has been increasingly questioned (Dixon, 1962; Dick, 1962; Kempe & Benenson, 1965 1963 19641965 1966 1967 1968 1962 1963 1964 1965 1966 1967 1968 Service, 1967) . However, the number of human deaths from rabies declined from thirtyfour in 1946 to one or two annually in recent years. This decline has resulted in great part from a reduction in rabies in dogs through immunization (United States Public Health Service, 1967 (Karzon, 1968a that measles or yellow fever vaccine virus may depress, at least in part, the replication of a second virus, presumably on the basis of interferon production. The maximum inhibition is during the second week following administration of the first virus. Thus, the recommendation that yellow fever vaccine be given at least 4 days before primary vaccination against smallpox (Ministry of Health, 1967a) may be expected to decrease the effectiveness of the smallpox take and antibody response (Karzon, 1968b care and regularity of contact between the family and health facilities. However, the latter situation is not always simple to achieve, and more direct efforts aimed specifically at attaining higher immunization rates can be successful, both as single mass community campaigns or in some form of ongoing program.
It is hoped that the information presented and the interpretations which have resulted will be a stimulus for others to continue to study comparative immunization practices.
